Affinity Asset Advisors »

Helix Acquisition Corp Ii Cl A shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 250k 10.45
2024-06-30 $2.6M 250k 10.22
2024-03-31 $2.6M 250k 10.35

More positions owned by Affinity Asset Advisors

Xenon Pharmaceuticals (XENE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Cassava Sciences Put Option (SAVA)
Apogee Therapeutics (APGE)
Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Vera Therapeutics Cl A (VERA)
Verona Pharma Sponsored Ads (VRNA)
Autolus Therapeutics Spon Ads (AUTL)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inozyme Pharma (INZY)

View all positions for Affinity Asset Advisors

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
BlackRock
Citadel Advisors
T. Rowe Price Associates
OZ Management
Farallon Capital Management
Perceptive Advisors
Dr. Jeffrey R. Jay, M.D.
Silverarc Capital Management
Commodore Capital
Soros Fund Management
T. Rowe Price Investment Management
Ghost Tree Capital
Laurion Capital Management

View all funds holding Helix Acquisition Corp Ii Cl A